EC
PMVP icon

EcoR1 Capital’s PMV Pharmaceuticals PMVP Stock Holding History

EcoR1 Capital’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-566,879
Closed -$964K – 64
2024
Q1 		$964K Hold
566,879
– – 0.02% 56
2023
Q4 		$1.76M Buy
+566,879
New +$1.5M 0.05% 47
2022
Q2 		– Sell
-649,786
Closed -$13.5M – 90
2022
Q1 		$13.5M Buy
649,786
+599,786
+1,200% +$10.6M 0.42% 39
2021
Q4 		$1.16M Hold
50,000
– – 0.04% 62
2021
Q3 		$1.49M Hold
50,000
– – 0.05% 58
2021
Q2 		$1.71M Hold
50,000
– – 0.06% 59
2021
Q1 		$1.65M Hold
50,000
– – 0.07% 58
2020
Q4 		$3.08M Hold
50,000
– – 0.17% 47
2020
Q3 		$1.77M Buy
+50,000
New +$1.84M 0.13% 42

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

EcoR1 Capital's PMVP Position: Q2 2024 in Review

EcoR1 Capital sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 566,879 shares — an estimated $964K sold.

EcoR1 Capital first reported a position in PMVP in Q3 2020 and held it in 9 quarters. The position peaked at $13.5M in Q1 2022. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • EcoR1 Capital reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • EcoR1 Capital sold 566,879 PMV Pharmaceuticals shares in Q2 2024, an estimated $964K.
  • EcoR1 Capital first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • EcoR1 Capital's PMV Pharmaceuticals position peaked at $13.5M in Q1 2022.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on EcoR1 Capital's 13F filing for Q2 2024, filed 14 Aug 2024.